Pages that link to "Q51886952"

The following pages link to Drug-induced serotonin syndrome: a review (Q51886952):

Displaying 35 items.

• Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions (Q24633393) (← links)
• Cardiac Effects of Opioid Therapy (Q28083959) (← links)
• 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). (Q34377010) (← links)
• Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? (Q35024842) (← links)
• Serotonin Syndrome in a Patient on Trazodone and Duloxetine Who Received Fentanyl following a Percutaneous Liver Biopsy (Q35725848) (← links)
• Conundrums in neurology: diagnosing serotonin syndrome - a meta-analysis of cases (Q36074323) (← links)
• Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome (Q37257186) (← links)
• CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity (Q37689364) (← links)
• A review of SSRIs and SNRIs in neuropathic pain (Q37773988) (← links)
• In Vitro Safety Pharmacology Profiling: What Else Beyond Herg? (Q37855844) (← links)
• Safety of rasagiline for the treatment of Parkinson's disease (Q37859776) (← links)
• Serotonin syndrome: take a closer look at the unwell surgical patient (Q37951236) (← links)
• Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. (Q38063789) (← links)
• Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs (Q38113748) (← links)
• Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression. (Q38124299) (← links)
• Perioperative management in children with chronic pain (Q38883801) (← links)
• Effects of opioids on human serotonin transporters (Q40230264) (← links)
• Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome (Q43321082) (← links)
• Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center (Q44557402) (← links)
• Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome (Q46232207) (← links)
• Regulatory Pathways of Monoamine Oxidase A during Social Stress (Q47171927) (← links)
• Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic (Q47261672) (← links)
• Serotonin syndrome caused by fentanyl and methadone in a burn injury. (Q47758109) (← links)
• Practical guide for prescribing MAOIs: debunking myths and removing barriers (Q48645946) (← links)
• Brain pathology in fatal serotonin syndrome: presentation of two cases (Q51836186) (← links)
• Meta-analysis of 5-hydroxytryptamine type 2A receptor polymorphisms and migraine susceptibility. (Q53149282) (← links)
• PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis. (Q53450108) (← links)
• Potential functional and pathological side effects related to off-target pharmacological activity. (Q53714273) (← links)
• Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain (Q57074830) (← links)
• Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex (Q82344883) (← links)
• Calamities in movement disorders (Q82728240) (← links)
• Drug-induced movement disorder and confusion associated with duloxetine (Q88204376) (← links)
• Serotonin toxicity (Q91360599) (← links)
• The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice (Q91923383) (← links)
• (Q93588057) (← links)